506 related articles for article (PubMed ID: 29503329)
21. Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs).
Utiumi MA; Felício AC; Borges CR; Braatz VL; Rezende SA; Munhoz RP; Bressan RA; Ferraz HB; Teive HA
Arq Neuropsiquiatr; 2012 Sep; 70(9):667-73. PubMed ID: 22990721
[TBL] [Abstract][Full Text] [Related]
22. 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET.
Huang WS; Ma KH; Chou YH; Chen CY; Liu RS; Liu JC
Nucl Med Commun; 2003 Jan; 24(1):77-83. PubMed ID: 12501023
[TBL] [Abstract][Full Text] [Related]
23. Imaging in Parkinson's disease.
Pagano G; Niccolini F; Politis M
Clin Med (Lond); 2016 Aug; 16(4):371-5. PubMed ID: 27481384
[TBL] [Abstract][Full Text] [Related]
24. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
[TBL] [Abstract][Full Text] [Related]
25. The role of molecular imaging in the differential diagnosis of parkinsonism.
Booij J; Teune LK; Verberne HJ
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):17-26. PubMed ID: 22460157
[TBL] [Abstract][Full Text] [Related]
26. Neuroimaging in Parkinson's Disease: necessity or exaggeration?
Śmiłowska K; Burzyńska-Makuch M; Brockhuis B; Piekarski R; Friedman A; Popek A; Sławek J
Neurol Neurochir Pol; 2021; 55(6):536-548. PubMed ID: 34637136
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
28. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
[TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.
Takaya S; Sawamoto N; Okada T; Okubo G; Nishida S; Togashi K; Fukuyama H; Takahashi R
Parkinsonism Relat Disord; 2018 Feb; 47():15-21. PubMed ID: 29157745
[TBL] [Abstract][Full Text] [Related]
30. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
[TBL] [Abstract][Full Text] [Related]
31. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
32. Molecular Imaging of Dementia With Lewy Bodies.
Cousins O; Yousaf T; Wilson H; Pagano G; Politis M
Int Rev Neurobiol; 2019; 144():59-93. PubMed ID: 30638457
[TBL] [Abstract][Full Text] [Related]
33. The utility of the combined use of
Matsusue E; Fujihara Y; Tanaka K; Aozasa Y; Shimoda M; Nakayasu H; Nakamura K; Ogawa T
Acta Radiol; 2019 Feb; 60(2):230-238. PubMed ID: 29804474
[TBL] [Abstract][Full Text] [Related]
34. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
Meyer PT; Amtage F; Hellwig S
Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
[TBL] [Abstract][Full Text] [Related]
35. The role of molecular imaging in assessing degenerative parkinsonism - an updated review.
Nicastro N; Garibotto V; Burkhard PR
Swiss Med Wkly; 2018; 148():w14621. PubMed ID: 29698545
[TBL] [Abstract][Full Text] [Related]
36. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions.
Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M
Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940
[TBL] [Abstract][Full Text] [Related]
37. Automatic classification of idiopathic Parkinson's disease and atypical Parkinsonian syndromes combining [
Martins R; Oliveira F; Moreira F; Moreira AP; Abrunhosa A; Januário C; Castelo-Branco M
J Neural Eng; 2021 Apr; 18(4):. PubMed ID: 33848996
[No Abstract] [Full Text] [Related]
38. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice.
Poewe W; Scherfler C
Mov Disord; 2003 Oct; 18 Suppl 7():S16-21. PubMed ID: 14531041
[TBL] [Abstract][Full Text] [Related]
39. PET Molecular Imaging in Atypical Parkinsonism.
Xu Z; Arbizu J; Pavese N
Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
[TBL] [Abstract][Full Text] [Related]
40. [Initial diagnosis of Parkinson's disease - neuroradiological diagnosis].
Orimo S
Rinsho Shinkeigaku; 2013; 53(11):977-80. PubMed ID: 24291851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
